Prognostic risk stratification of patients with urothelial carcinoma of the bladder with recurrence after radical cystectomy

Journal of Urology

Volumn 189, Issue 4, 2013, Pages 1275-1281

  Nakagawa, Tohru ^a   Hara, Tomohiko ^a   Kawahara, Takashi ^a   Ogata, Yoshihiko ^a   Nakanishi, Hiroyuki ^a   Komiyama, Motokiyo ^a   Arai, Eri ^a,b   Kanai, Yae ^a,b   Fujimoto, Hiroyuki ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

local; neoplasm recurrence; prognosis; risk; urinary bladder; urinary bladder neoplasms

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; C REACTIVE PROTEIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; PLATINUM;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CYSTECTOMY; DISEASE MODEL; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LEUKOCYTE COUNT; LIVER METASTASIS; LOG RANK TEST; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS RESECTION; OVERALL SURVIVAL; PATHOLOGY; PHYSICIAN; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; RECURRENT CANCER; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; URINARY BLADDER NEOPLASMS;

EID: 84875951412     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.10.065     Document Type: Article

References (20)

1. J.P. Stein, D.G. Skinner Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure World J Urol 24 2006 296
2. J.P. Stein, G. Lieskovsky, R. Cote Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients J Clin Oncol 19 2001 666
3. S. Madersbacher, W. Hochreiter, F. Burkhard Radical cystectomy for bladder cancer today - a homogeneous series without neoadjuvant therapy J Clin Oncol 21 2003 690
4. S.F. Shariat, P.I. Karakiewicz, G.S. Palapattu Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium J Urol 176 2006 2414
5. R.E. Hautmann, J.E. Gschwend, R.C. de Petriconi Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era J Urol 176 2006 486
6. F.A. Yafi, A.G. Aprikian, J.L. Chin Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience BJU Int 108 2011 539
7. B.G. Volkmer, R. Kuefer, G.C. Bartsch Jr Oncological followup after radical cystectomy for bladder cancer - is there any benefit? J Urol 181 2009 1587
8. A.P. Mitra, D.I. Quinn, T.B. Dorff Factors influencing post-recurrence survival in bladder cancer following radical cystectomy BJU Int 109 2012 846
9. L.H. Sobin, M.K. Gospodarowicz, C. Wittekind TNM Classification of Malignant Tumors 7th ed. 2009 Wiley Hoboken
10. G. Giannarini, T.M. Kessler, H.C. Thoeny Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution? Eur Urol 58 2010 486
11. S.A. Boorjian, M.K. Tollefson, J.C. Cheville Detection of asymptomatic recurrence during routine oncological followup after radical cystectomy is associated with improved patient survival J Urol 186 2011 1796
12. D.C. McMillan, K. Canna, C.S. McArdle Systemic inflammatory response predicts survival following curative resection of colorectal cancer Br J Surg 90 2003 215
13. M. Ikeda, S. Natsugoe, S. Ueno Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma Ann Surg 238 2003 197
14. N.B. Jamieson, P. Glen, D.C. McMillan Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas Br J Cancer 92 2005 21
15. G. Gakis, T. Todenhöfer, M. Renninger Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score BJU Int 108 2011 1800
16. S. Yoshida, K. Saito, F. Koga C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy BJU Int 10 2008 978
17. M. Hilmy, J.M. Bartlett, M.A. Underwood The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder Br J Cancer 92 2005 625
18. T. Kouno, M. Ando, K. Yonemori Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen Eur Urol 52 2007 1115
19. J. Lehmann, H. Suttmann, P. Albers Surgery for metastatic urothelial carcinoma with curative intent: the German experience (AUO AB 30/05) Eur Urol 55 2009 1293
20. H. von der Maase, L. Sengelov, J.T. Roberts Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer J Clin Oncol 23 2005 4602